These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28881094)

  • 1. Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward.
    Martiniano SL; Davidson RM; Nick JA
    Pediatr Pulmonol; 2017 Nov; 52(S48):S29-S36. PubMed ID: 28881094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nontuberculous Mycobacteria in Cystic Fibrosis.
    Richards CJ; Olivier KN
    Semin Respir Crit Care Med; 2019 Dec; 40(6):737-750. PubMed ID: 31659731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontuberculous mycobacterial infections in cystic fibrosis.
    Martiniano SL; Nick JA
    Clin Chest Med; 2015 Mar; 36(1):101-15. PubMed ID: 25676523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.
    Martiniano SL; Esther CR; Haworth CS; Kasperbauer SH; Zemanick ET; Caverly LJ
    Pediatr Pulmonol; 2020 Feb; 55(2):521-525. PubMed ID: 31821718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].
    Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J
    Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.
    Leung JM; Olivier KN
    Curr Opin Pulm Med; 2013 Nov; 19(6):662-9. PubMed ID: 24048085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2016 Mar; 37(1):83-96. PubMed ID: 26857770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
    Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA
    Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient Complement Opsonization Impairs Mycobacterium avium Killing by Neutrophils in Cystic Fibrosis.
    Lenhart-Pendergrass PM; Malcolm KC; Wheeler E; Rysavy NM; Poch K; Caceres S; Calhoun KM; Martiniano SL; Nick JA
    Microbiol Spectr; 2023 Feb; 11(1):e0327922. PubMed ID: 36651756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Thorac Surg Clin; 2019 Feb; 29(1):95-108. PubMed ID: 30454926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helping map the taxonomical position of the Nontuberculous Mycobacteria (NTM) in cystic fibrosis.
    Moore JE; Millar BC
    Int J Mycobacteriol; 2022; 11(3):303-308. PubMed ID: 36260450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2022 Dec; 43(4):697-716. PubMed ID: 36344075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study.
    Saint GL; Thomas MF; Zainal Abidin N; Langley RJ; Brodlie M; McNamara P;
    Arch Dis Child; 2022 May; 107(5):479-485. PubMed ID: 34740877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019).
    Marshall JE; Mercaldo RA; Lipner EM; Prevots DR
    BMC Infect Dis; 2023 Jul; 23(1):489. PubMed ID: 37488500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.
    Coolen N; Morand P; Martin C; Hubert D; Kanaan R; Chapron J; Honoré I; Dusser D; Audureau E; Veziris N; Burgel PR
    J Cyst Fibros; 2015 Sep; 14(5):594-9. PubMed ID: 25735458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program.
    Gross JE; Caceres S; Poch K; Hasan NA; Jia F; Epperson LE; Lipner E; Vang C; Honda JR; Strand M; Calado Nogueira de Moura V; Daley CL; Strong M; Davidson RM; Nick JA
    Am J Respir Crit Care Med; 2022 May; 205(9):1064-1074. PubMed ID: 35085056
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.
    Burke A; Smith D; Coulter C; Bell SC; Thomson R; Roberts JA
    Clin Pharmacokinet; 2021 Sep; 60(9):1081-1102. PubMed ID: 33982266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic Fibrosis-Related Nontuberculous Mycobacterial Pulmonary Disease.
    Baird T; Bell S
    Clin Chest Med; 2023 Dec; 44(4):847-860. PubMed ID: 37890921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.
    Martiniano SL; Wagner BD; Levin A; Nick JA; Sagel SD; Daley CL
    Chest; 2017 Oct; 152(4):800-809. PubMed ID: 28483608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontuberculous mycobacteria in the setting of cystic fibrosis.
    Ebert DL; Olivier KN
    Clin Chest Med; 2002 Sep; 23(3):655-63. PubMed ID: 12371001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.